Japanese startup Space One Co. will launch a Kairos small rocket carrying artificial satellites on Feb. 25 next year after two failed attempts. The Tokyo-based company aims to be Japan's first to put ...
Two Manitoba women were in Bethlehem last month to witness the launch of a call to action about the plight of Palestinian ...
Every Wednesday night, runners gather along the Trinity River levee in Dallas for Kairos Run Club's weekly run. After the work day is done, and before the sun sets, hundreds of runners gather at the ...
With concrete already being poured, this startup’s molten salt–cooled reactors could be the first to deliver cheaper, safer nuclear power. Like many new nuclear startups, Kairos promises a path to ...
LOS ANGELES - Kairos Pharma, Ltd. (NYSE American:KAPA) announced Thursday that its Phase 2 clinical trial of ENV105 (carotuximab) in combination with apalutamide showed positive interim efficacy ...
LOS ANGELES - Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company with a market capitalization of $28 million, announced Wednesday that initial Phase 1 data for its ...
Kairos Pharma is currently conducting a Phase 2 clinical trial of ENV105 for castrate-resistant prostate cancer alongside this Phase 1 trial for lung cancer. The clinical-stage biopharmaceutical ...
LOS ANGELES - Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company with a market capitalization of $28 million, announced Wednesday that initial Phase 1 data for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback